You may be suitable for the Wegovy pill if you are an adult with: A BMI of 30 or above (clinically classified as obesity), or A BMI of 27 or above with at least one weight-related health condition such as high blood pressure, raised cholesterol, type 2 diabetes, prediabetes or obstructive sleep apnoea The Wegovy pill is not suitable if you: Are pregnant, breastfeeding or planning a pregnancy Have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Are allergic to semaglutide or any of the inactive ingredients Tell your doctor, who will assess whether it is appropriate, if you: Have a history of pancreatitis or severe gastrointestinal disease Have gallbladder problems or severe kidney disease The OASIS 4 trial that supported the UK approval did not include people with type 2 diabetes
J., Mezquita-Raya, P., Carretero-Gmez, J., et al (2022)
In the UK, Wegovy is utilised for weight loss and obesity treatment [4]
For example, one of our members (name withheld for privacy) combined semaglutide with a balanced diet and regular exercise, achieving a 10% weight loss over six months and improved blood sugar control
*Fridays does not manufacture compounded medications